Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Bausch + Lomb Corporation BLCO

Healthcare  —  Medical Instruments & Supplies
16.86 0.06 0.36% as of 25 Sep
Market cap
$6.0B
P/E
0.0×
Revenue Champion (5y) Insider Buys (last 12m)
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Bausch + Lomb Corporation (BLCO) Business Profile

Updated before January 2025

Company Overview

Bausch + Lomb Corporation (BLCO) is a leading global eye health company dedicated to protecting and enhancing the gift of sight for millions of people worldwide. Founded in 1853 by John Jacob Bausch and Henry Lomb in Rochester, New York, the company has a rich history of innovation and excellence in the field of eye care. Over the years, Bausch + Lomb has grown into a trusted name in the industry, offering a comprehensive portfolio of products that address a wide range of eye health needs.

The company is headquartered in Vaughan, Ontario, Canada, and operates in over 100 countries. Bausch + Lomb is led by a team of experienced executives, including CEO Brent Saunders, who has a strong track record in the healthcare and pharmaceutical industries. Under his leadership, the company continues to focus on innovation, customer-centric solutions, and sustainable growth.

Core Business Segments

Bausch + Lomb operates across three primary business segments, each catering to different aspects of eye health:

1. Vision Care

This segment includes a wide range of contact lenses and lens care products. Bausch + Lomb is renowned for its high-quality contact lenses, which are designed to meet the diverse needs of consumers. Key products include:

  • Biotrue ONEday Contact Lenses: Daily disposable lenses that provide exceptional comfort and moisture retention.
  • Ultra Contact Lenses: Monthly lenses featuring MoistureSeal technology for long-lasting comfort.
  • SofLens Contact Lenses: Affordable and reliable lenses for daily or extended wear.
  • Lens Care Solutions: Products like Biotrue Multi-Purpose Solution and Renu Advanced Formula for cleaning and maintaining contact lenses.

2. Pharmaceuticals

The pharmaceutical segment focuses on prescription and over-the-counter (OTC) eye health products. These include treatments for various eye conditions such as dry eye, glaucoma, and ocular inflammation. Notable products include:

  • Lotemax: A corticosteroid used to treat inflammation and pain following eye surgery.
  • Prolensa: A nonsteroidal anti-inflammatory drug (NSAID) for post-operative inflammation.
  • PreserVision: A leading OTC eye vitamin supplement designed to support macular health.
  • Lumify: A popular OTC redness reliever eye drop.

3. Surgical

The surgical segment provides advanced technologies and equipment for ophthalmic surgeries. This includes products for cataract, vitreoretinal, and refractive surgeries. Key offerings include:

  • Stellaris Elite Vision Enhancement System: A state-of-the-art platform for cataract and retinal surgeries.
  • Crystalens and Trulign Toric Intraocular Lenses (IOLs): Premium lenses for cataract patients seeking improved vision.
  • Surgical Instruments and Accessories: A comprehensive range of tools for ophthalmic procedures.

Business Model

Bausch + Lomb’s business model is centered around innovation, customer satisfaction, and a diversified product portfolio. The company integrates its products and services to provide end-to-end solutions for eye health. Revenue is generated through the sale of contact lenses, pharmaceuticals, surgical equipment, and related services. The company also invests heavily in research and development (R&D) to bring new and improved products to market, ensuring a steady pipeline of innovations.

BLCO leverages its global presence and strong distribution network to reach customers in both developed and emerging markets. The company collaborates with healthcare professionals, optometrists, and ophthalmologists to deliver high-quality eye care solutions.

Strategic Direction

Bausch + Lomb is committed to driving growth through innovation, sustainability, and market expansion. Key strategic priorities include:

  • Product Innovation: Developing new technologies and products to address unmet needs in eye health.
  • Geographic Expansion: Strengthening its presence in emerging markets with high growth potential.
  • Sustainability Goals: Reducing the environmental impact of its operations and products. Initiatives include eco-friendly packaging and sustainable manufacturing practices.
  • Digital Transformation: Leveraging digital tools and platforms to enhance customer engagement and streamline operations.
  • Mergers and Acquisitions: Exploring strategic partnerships and acquisitions to expand its product portfolio and market reach.

Competitive Landscape

Bausch + Lomb operates in a highly competitive industry, facing competition from both established players and new entrants. Key competitors include:

  • Alcon: A global leader in eye care, offering a wide range of surgical, vision care, and pharmaceutical products.
  • Johnson & Johnson Vision: Known for its Acuvue contact lenses and surgical solutions.
  • CooperVision: A major player in the contact lens market.
  • Allergan (a subsidiary of AbbVie): Competes in the pharmaceutical segment with products for dry eye and other conditions.
  • Carl Zeiss Meditec: Specializes in surgical and diagnostic equipment for ophthalmology.

Risk Factors

Bausch + Lomb faces several risks that could impact its business operations and financial performance:

  • Market Dependence: Reliance on the sale of contact lenses and pharmaceuticals makes the company vulnerable to market fluctuations and changing consumer preferences.
  • Regulatory Challenges: Compliance with stringent regulations in different countries can be complex and costly.
  • Supply Chain Disruptions: Dependence on global supply chains exposes the company to risks such as raw material shortages and transportation delays.
  • Competition: Intense competition in the eye care industry could pressure pricing and margins.
  • Economic Conditions: Economic downturns and reduced consumer spending could affect demand for elective eye care products and services.

Recent Developments

Bausch + Lomb has made significant strides in recent years, including:

  • Launch of New Products: Introduction of innovative products like the Ultra Multifocal for Astigmatism contact lenses and the ClearVisc dispersive ophthalmic viscosurgical device (OVD).
  • Sustainability Initiatives: Expansion of the ONE by ONE Recycling Program, which allows consumers to recycle used contact lenses and packaging.
  • Corporate Strategies: Strengthening its R&D capabilities and forming strategic partnerships to drive growth.
  • Global Developments: Navigating challenges posed by the COVID-19 pandemic, including supply chain disruptions and changes in consumer behavior.

Investment Considerations

Investors considering Bausch + Lomb should weigh the following factors:

Strengths:

  • Strong brand recognition and a long history of excellence in eye care.
  • Diversified product portfolio catering to various aspects of eye health.
  • Global presence and robust distribution network.
  • Commitment to innovation and sustainability.

Risks:

  • Dependence on key product categories and markets.
  • Exposure to regulatory and competitive pressures.
  • Potential supply chain disruptions and economic uncertainties.

Conclusion

Bausch + Lomb Corporation is a trusted leader in the global eye care industry, with a rich history, a diversified product portfolio, and a commitment to innovation and sustainability. While the company faces challenges such as competition and regulatory complexities, its strategic initiatives and strong market position provide a solid foundation for future growth. As the demand for eye health solutions continues to rise, Bausch + Lomb is well-positioned to capitalize on emerging opportunities and deliver value to its customers and shareholders.